Breaking News

Thermo Fisher Scientific Launches Efficient-Pro Medium (+) Insulin  

Designed to increase titers and enhance bioprocessing performance of insulin-dependent CHO cell lines.

Thermo Fisher Scientific launched the Gibco Efficient-Pro Medium (+) Insulin, a next-generation medium designed to increase titers to maximize productivity and performance of insulin-dependent CHO cell lines.  Designed for biopharma manufacturers and CDMOs focused on CHO-based therapeutics, efficient-Pro Medium (+) Insulin is designed to offer improved protein yield and optimized productivity for insulin-dependent CHO cell lines commonly used in monoclonal antibody and biosimilar production, ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters